Indian pharmaceutical company Lupin announced that Dr. Shahin Fesharaki has been appointed as Global Chief Scientific Officer who will handle global research and development works across generics, branded, and specialty products. Vinita Gupta – Lupin CEO and Lupin MD Nilesh Gupta said: “We are very pleased to welcome Shahin to our leadership team. Shahin’s exceptional […]
Lupin Limited has entered into partnerships with Unitaid, the Clinton Health Access Initiative (CHAI), The Aurum Institute, and other global procurement agencies for supporting tuberculosis (TB) prevention treatment. According to the Indian pharma company, the TB prevention treatment will be launched in 138 countries, including several low-and middle-income countries that are faced with a large […]
Indian pharma company Lupin Limited has launched Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, after getting an approval from the United States Food and Drug Administration (FDA). Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces is a generic […]
Lupin Limited has secured approval from Health Canada for Rymti, the company’s biosimilar to Enbrel (etanercept), an inhibitor of tumour necrosis factor (TNF). Rymti is approved for the treatment of rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, plaque psoriasis, and paediatric plaque psoriasis. Lupin said that Rymti is available in Canada as an […]
Lupin through its subsidiary — Lupin Healthcare (UK) has secured approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Lutio, a generic version of Spiriva (Tiotropium bromide). Lutio has been approved for the treatment of chronic obstructive pulmonary disease (COPD). It is the second inhalation product for the British market from Lupin […]
Lupin said that its recently created diagnostics business — Lupin Diagnostics has opened its reference laboratory in Guwahati in line with the latter’s strategy to grow its footprint in India. This follows Lupin Diagnostics’ opening of a reference laboratory in Kolkata. The Lupin Diagnostics lab in Guwahati can perform a range of routine and specialized […]
Lupin Limited said that its recently created diagnostics business — Lupin Diagnostics has opened its first reference laboratory in eastern India at Kolkata. The new reference laboratory can carry out a wide spectrum of routine and specialized tests in the areas of molecular diagnostics, flow cytometry, cytogenetics, cytology, histopathology, serology, microbiology, immunology, haematology, and routine […]
Lupin Limited said that it has secured approval for Vigabatrin for Oral Solution USP, 500 mg, an anti-epileptic drug, from the US Food and Drug Administration (FDA). The US pharma regulator approved the abbreviated new drug application (ANDA) of the Lupin product, which is a generic of Sabril for Oral Solution, 500 mg owned by […]
Lupin Pharmaceuticals has secured approval from the US Food and Drug Administration for its supplemental new drug application (sNDA) to expand the indication of SOLOSEC (secnidazole) in the treatment of bacterial vaginosis (BV) for female patients, aged 12 and more and in the treatment of trichomoniasis for all patients, aged 12 and more. Bacterial vaginosis […]
Lupin Limited said that it has secured approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for Sevelamer Carbonate for Oral Suspension, 0.8 g and 2.4 g packets. Sevelamer Carbonate is a generic equivalent of Renvela for Oral Suspension, 0.8 g and 2.4 g Packets of Genzyme. Lupin […]